Jain R - Search Results

1

Dual role of Nrf2 in cancer: molecular mechanisms, cellular functions and therapeutic interventions.

Poornashree M, Kumar H, Ajmeer R, Jain R, Jain V. Poornashree M, et al. Among authors: jain r, jain v. Mol Biol Rep. 2023 Feb;50(2):1871-1883. doi: 10.1007/s11033-022-08126-1. Epub 2022 Dec 13. Mol Biol Rep. 2023. PMID: 36513865 Review.

2

Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors.

Dinakar YH, Kumar H, Mudavath SL, Jain R, Ajmeer R, Jain V. Dinakar YH, et al. Among authors: jain r, jain v. Life Sci. 2022 Nov 15;309:120996. doi: 10.1016/j.lfs.2022.120996. Epub 2022 Sep 25. Life Sci. 2022. PMID: 36170890 Review.

3

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer.

Kumar H, Gupta NV, Jain R, Madhunapantula SV, Babu CS, Kesharwani SS, Dey S, Jain V. Kumar H, et al. Among authors: jain r, jain v. J Adv Res. 2023 Dec;54:271-292. doi: 10.1016/j.jare.2023.02.005. Epub 2023 Feb 14. J Adv Res. 2023. PMID: 36791960 Free PMC article. Review.

4

Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery.

Mishra S, Bhatt T, Kumar H, Jain R, Shilpi S, Jain V. Mishra S, et al. Among authors: jain r, jain v. Front Pharmacol. 2023 Mar 15;14:1101320. doi: 10.3389/fphar.2023.1101320. eCollection 2023. Front Pharmacol. 2023. PMID: 37007005 Free PMC article. Review.

5

Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics.

Kumar RM, Kumar H, Bhatt T, Jain R, Panchal K, Chaurasiya A, Jain V. Kumar RM, et al. Among authors: jain r, jain v. Pharmaceuticals (Basel). 2023 Jan 28;16(2):196. doi: 10.3390/ph16020196. Pharmaceuticals (Basel). 2023. PMID: 37259344 Free PMC article. Review.

6

F3 peptide functionalized liquid crystalline nanoparticles for delivering Salinomycin against breast cancer.

Kumar H, Gupta NV, Jain R, Madhunapantula SV, Babu S, Dey S, Soni AG, Jain V. Kumar H, et al. Among authors: jain r, jain v. Int J Pharm. 2023 Aug 25;643:123226. doi: 10.1016/j.ijpharm.2023.123226. Epub 2023 Jul 13. Int J Pharm. 2023. PMID: 37451328

7

The multifaceted role of extracellular vesicles in prostate cancer-a review.

Jain DP, Dinakar YH, Kumar H, Jain R, Jain V. Jain DP, et al. Among authors: jain r, jain v. Cancer Drug Resist. 2023 Jul 28;6(3):481-498. doi: 10.20517/cdr.2023.17. eCollection 2023. Cancer Drug Resist. 2023. PMID: 37842237 Free PMC article. Review.

8

Fisetin-Loaded Nanostructured Lipid Carriers: Formulation and Evaluations against Advanced and Metastatic Melanoma.

Kumar H, Chand P, Pachal S, Mallick S, Jain R, Madhunapantula SV, Jain V. Kumar H, et al. Among authors: jain r, jain v. Mol Pharm. 2023 Dec 4;20(12):6035-6055. doi: 10.1021/acs.molpharmaceut.3c00309. Epub 2023 Oct 31. Mol Pharm. 2023. PMID: 37906601

9

A Two-Stage Training Framework Using Multicontrast MRI Radiomics for IDH Mutation Status Prediction in Glioma.

Truong NCD, Bangalore Yogananda CG, Wagner BC, Holcomb JM, Reddy D, Saadat N, Hatanpaa KJ, Patel TR, Fei B, Lee MD, Jain R, Bruce RJ, Pinho MC, Madhuranthakam AJ, Maldjian JA. Truong NCD, et al. Among authors: jain r. Radiol Artif Intell. 2024 May 22:e230218. doi: 10.1148/ryai.230218. Online ahead of print. Radiol Artif Intell. 2024. PMID: 38775670

10

Patterns and Outcomes in Pediatric Abdominal Tuberculosis: A Single Centre Cohort Study.

John S, Ghosh D, Michael V, Kruger D, Jain R, Dhir K, Mohan S, Bhangu A. John S, et al. Among authors: jain r. J Pediatr Surg. 2024 Apr 22:S0022-3468(24)00257-4. doi: 10.1016/j.jpedsurg.2024.04.006. Online ahead of print. J Pediatr Surg. 2024. PMID: 38769032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,303 results

Search Page